Japan Unified Protocol Clinical Trial for Depressive and Anxiety Disorders (JUNP study): study protocol for a randomized controlled trial

Masaya Ito, Yasuyuki Okumura, Masaru Horikoshi, Noriko Kato, Yuki Oe, Mitsuhiro Miyamae, Naotsugu Hirabayashi, Ayako Kanie, Atsuo Nakagawa, Yutaka Ono, Masaya Ito, Yasuyuki Okumura, Masaru Horikoshi, Noriko Kato, Yuki Oe, Mitsuhiro Miyamae, Naotsugu Hirabayashi, Ayako Kanie, Atsuo Nakagawa, Yutaka Ono

Abstract

Background: The unified protocol for the transdiagnostic treatment of emotional disorders is a promising treatment approach that could be applicable to a broad range of mental disorders, including depressive, anxiety, trauma-related, and obsessive-compulsive disorders. However, no randomized controlled trial has been conducted to verify the efficacy of the unified protocol on the heterogeneous clinical population with depressive and anxiety disorders.

Methods/design: The trial was designed as a single-center, assessor-blinded, randomized, 20-week, parallel-group superiority study in order to compare the efficacy of the combination of unified protocol and treatment-as-usual versus waiting-list with treatment-as-usual for patients with depressive and/or anxiety disorders. The primary outcome was depression at 21 weeks, assessed by the 17-item version of the GRID-Hamilton Rating Scale for Depression. Estimated minimum sample size was 27 participants in each group. We will also examine the treatment mechanisms, treatment processes, and neuropsychological correlates.

Discussion: The results of this study will clarify the efficacy of the unified protocol for depressive and anxiety disorders, and the treatment mechanism, process, and neurological correlates for the effectiveness of the unified protocol. If its efficacy can be confirmed, the unified protocol may be of high clinical value for Japan, a country in which cognitive behavioral treatment has not yet been widely adopted.

Trial registration: ClinicalTrials.gov NCT02003261 (registered on December 2, 2013).

Keywords: Anxiety disorder; Depressive disorder; Emotion; Randomized controlled trial; Transdiagnostic; Unified protocol.

Figures

Fig. 1
Fig. 1
CONSORT diagram for this clinical trial

References

    1. Kawakami N. Epidemiological survey for mental health. Tokyo: Ministry of Health Labour and Welfare of Japan; 2006.
    1. Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the national comorbidity survey replication. Arch Gen Psychiatry. 2005;62(6):593–602. doi: 10.1001/archpsyc.62.6.593.
    1. Vos T, Barber RM, Bell B, Bertozzi-Villa A, Biryukov S, Bolliger I, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013, a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2013;386(9995):743–800.
    1. World Health Organization . The global burden of disease: 2004 update. Geneva: WHO Press; 2008.
    1. Greenberg PE, Fournier AA, Sisitsky T, Pike CT, Kessler RC. The economic burden of adults with major depressive disorder in the United States (2005 and 2010) J Clin Psychiatry. 2015;76(2):155–162. doi: 10.4088/JCP.14m09298.
    1. Okumura Y, Higuchi T. Cost of depression among adults in Japan. Prim Care Companion CNS Disord. 2011;13(3):PCC.10m01082.
    1. Sado M, Yamauchi K, Kawakami N, Ono Y, Furukawa TA, Tsuchiya M, et al. Cost of depression among adults in Japan in 2005. Psychiatry Clin Neurosci. 2011;65(5):442–450. doi: 10.1111/j.1440-1819.2011.02237.x.
    1. Greenberg PE, Sisitsky T, Kessler RC, Finkelstein SN, Berndt ER, Davidson JR, et al. The economic burden of anxiety disorders in the 1990s. J Clin Psychiatry. 1999;60(7):427–435. doi: 10.4088/JCP.v60n0702.
    1. Sado M, Takechi S, Inagaki A, Fujisawa D, Koreki A, Mimura M, et al. Cost of anxiety disorders in Japan in 2008: a prevalence-based approach. BMC Psychiatry. 2013;13:338–340. doi: 10.1186/1471-244X-13-338.
    1. Kessler RC, Greenberg PE. The economic burden of anxiety and stress disorders. Neuropsychopharmacology. 2002;67:982–992.
    1. Barlow DH, Allen LB, Choate ML. Toward a unified treatment for emotional disorders. Behav Ther. 2004;35(2):205–230. doi: 10.1016/S0005-7894(04)80036-4.
    1. Norton PJ, Paulus DJ. Toward a unified treatment for emotional disorders: update on the science and practice. Behavior Therapy. 2015. ISSN 0005-7894. .
    1. Wilamowska ZA, Thompson-Hollands J, Fairholme CP, Ellard KK, Farchione TJ, Barlow DH, et al. Conceptual background, development, and preliminary data from the unified protocol for transdiagnostic treatment of emotional disorders. Depress Anxiety. 2010;27(10):882–890. doi: 10.1002/da.20735.
    1. Watkins E. An alternative transdiagnostic mechanistic approach to affective disorders illustrated with research from clinical psychology. Emotion Review. 2015;7(3):250–255. doi: 10.1177/1754073915575400.
    1. Rosellini A, Boettcher H, Brown T, Barlow DH. A transdiagnostic temperament-phenotype profile approach to emotional disorder classification: an update. Psychopathol Rev. 2015;2(1):110–128. doi: 10.5127/pr.036014.
    1. Krueger RF, Eaton NR. Transdiagnostic factors of mental disorders. World Psychiatry. 2015;14(1):27–29. doi: 10.1002/wps.20175.
    1. American Psychiatric Association . Diagnostic and statistical manual-5. Washington: American Psychiatric Association; 2013.
    1. Butler AC, Chapman JE, Forman EM, Beck AT. The empirical status of cognitive-behavioral therapy: a review of meta-analyses. Clin Psychol Rev. 2006;26(1):17–31. doi: 10.1016/j.cpr.2005.07.003.
    1. Hofmann SG, Asnaani A, Vonk IJ, Sawyer AT, Fang A. The efficacy of cognitive behavioral therapy: a review of meta-analyses. Cogn Ther Res. 2012;36(5):427–440. doi: 10.1007/s10608-012-9476-1.
    1. National Collaborating Centre for Mental Health . Depression: the treatment and management of depression in adults. Updated ed. Leicester: British Psychological Society/London: Royal College of Psychiatrists; 2010.
    1. McIntosh A, Cohen A, Turnbull N, Esmonde L, Dennis P, Eatock J, et al. Clinical guidelines and evidence review for panic disorder and generalised anxiety disorder. Sheffield: University of Sheffield/London: National Collaborating Centre for Primary Care; 2004.
    1. National Collaborating Centre for Mental Health . Common mental health disorders: identification and pathways to care. Leicester: British Psychological Society/London: Royal College of Psychiatrists; 2011.
    1. National Collaborating Centre for Mental Health . Social anxiety disorder: recognition, assessment and treatment. Leicester: British Psychological Society/London: Royal College of Psychiatrists; 2013.
    1. National Collaborating Centre for Mental Health and Clinical Excellence . Post-traumatic stress disorder: the management of PTSD in adults and children in primary and secondary care. Leicester: British Psychological Society/London: Royal College of Psychiatrists; 2005.
    1. Gelenberg AJ, Freeman MP, Markowitz JC, Rosenbaum JF, Thase ME, Trivedi MH, et al. Practice guideline for the treatment of patients with major depressive disorder. 3rd ed. Am J Psych. 2010;167(10):1–152.
    1. Koran LM, Simpson HB. Guideline watch (March 2013): practice guideline for the treatment of patients with obsessive-compulsive disorder. Arlington: American Psychiatric Association; 2013.
    1. Stein MB, Goin MK, Roy-Byrne P, Sareen J, Simon N, Campbell-Sills L. Practice guideline for the treatment of patients with panic disorder. 2. Arlington: American Psychiatric Association; 2010.
    1. Jonas DE, Cusack K, Forneris CA, Wilkins TM, Sonis J, Middleton JC, et al. AHRQ comparative effectiveness reviews: psychological and pharmacological treatments for adults with posttraumatic stress disorder (PTSD) Rockville: Agency for Healthcare Research and Quality (US); 2013.
    1. Mansell W, Harvey A, Watkins E, Shafran R. Conceptual foundations of the transdiagnostic approach to CBT. J Cogn Psychother. 2009;23(1):6–19. doi: 10.1891/0889-8391.23.1.6.
    1. McManus F, Shafran R, Cooper Z. What does a transdiagnostic approach have to offer the treatment of anxiety disorders? Br J Clin Psychol. 2010;49(Pt 4):491–505. doi: 10.1348/014466509X476567.
    1. Clark DA. Cognitive behavioral therapy for anxiety and depression: possibilities and limitations of a transdiagnostic perspective. Cognitive Behaviour Therapy. 2009;38(Suppl 1):29–34. doi: 10.1080/16506070902980745.
    1. Newby JM, McKinnon A, Kuyken W, Gilbody S, Dalgleish T. Systematic review and meta-analysis of transdiagnostic psychological treatments for anxiety and depressive disorders in adulthood. Clin Psychol Rev. 2015;40:91–110. doi: 10.1016/j.cpr.2015.06.002.
    1. Reinholt N, Krogh J. Efficacy of rransdiagnostic cognitive behaviour therapy for anxiety disorders: a systematic review and meta-analysis of published outcome studies. Cogn Behav Ther. 2014;43(3):171–184. doi: 10.1080/16506073.2014.897367.
    1. Fairholme CP, Boisseau CL, Ellard KK, Ehrenreich J, Barlow DH. Emotion regulation and psychopathology: a transdiagnostic approach to etiology and treatment. New York: Guilford Press; 2010. Emotions, emotion regulation, and psychological treatment: a unified perspective; pp. 283–309.
    1. Barlow DH, Farchione TJ, Fairholme CP, Ellard KK, Boisseau CL, Allen LB, et al. Unified protocol for transdiagnostic treatment of emotional disorders: therapist guide. New York: Oxford University Press; 2011.
    1. Boswell JF, Anderson LM, Barlow DH. An idiographic analysis of change processes in the unified transdiagnostic treatment of depression. J Consult Clin Psychol. 2014;82(6):1060–1071. doi: 10.1037/a0037403.
    1. Ellard KK, Fairholme CP, Boisseau CL, Farchione TJ, Barlow DH. Unified protocol for the transdiagnostic treatment of emotional disorders: protocol development and initial outcome data. Cogn Behav Pract. 2010;17(1):88–101. doi: 10.1016/j.cbpra.2009.06.002.
    1. Farchione TJ, Fairholme CP, Ellard KK, Boisseau CL, Thompson-Hollands J, Carl JR, et al. Unified protocol for transdiagnostic treatment of emotional disorders: a randomized controlled trial. Behav Ther. 2012;43(3):666–678. doi: 10.1016/j.beth.2012.01.001.
    1. de Ornelas Maia ACC, Nardi AE, Cardoso A. The utilization of unified protocols in behavioral cognitive therapy in transdiagnostic group subjects: a clinical trial. J Affect Disord. 2015;172:179–183. doi: 10.1016/j.jad.2014.09.023.
    1. Ellard KK, Deckersbach T, Sylvia LG, Nierenberg AA, Barlow DH. Transdiagnostic treatment of bipolar disorder and comorbid anxiety with the unified protocol: a clinical replication series. Behav Modif. 2012;36(4):482–508. doi: 10.1177/0145445512451272.
    1. Sauer-Zavala S, Bentley KH, Wilner JG. Transdiagnostic treatment of borderline personality disorder and comorbid disorders: a clinical replication series. J Personal Disord. 2015;24:1–17.
    1. Ehrenreich JT, Goldstein CM, Wright LR, Barlow DH. Development of a unified protocol for the treatment of emotional disorders in youth. Child Fam Behav Ther. 2009;31(1):20–37. doi: 10.1080/07317100802701228.
    1. Gros DF. Design challenges in transdiagnostic psychotherapy research: comparing Transdiagnostic Behavior Therapy (TBT) to existing evidence-based psychotherapy in veterans with affective disorders. Contemp. Clin. Trials. 2015;43:114–119. doi: 10.1016/j.cct.2015.05.011.
    1. Barlow DH, Sauer-Zavala S, Carl JR, Bulis JR, Ellard KK. The nature, diagnosis, and treatment of neuroticism: Back to the future. Clin Psychol Sci. 2014;2(3):344–365. doi: 10.1177/2167702613505532.
    1. Sauer-Zavala S, Boswell JF, Gallagher MW, Bentley KH, Ametaj A, Barlow DH. The role of negative affectivity and negative reactivity to emotions in predicting outcomes in the unified protocol for the transdiagnostic treatment of emotional disorders. Behav Res Ther. 2012;50(9):551–557. doi: 10.1016/j.brat.2012.05.005.
    1. Berking M, Wupperman P, Reichardt A, Pejic T, Dippel A, Znoj H. Emotion-regulation skills as a treatment target in psychotherapy. Behav Res Ther. 2008;46(11):1230–1237. doi: 10.1016/j.brat.2008.08.005.
    1. Glenn D, Golinelli D, Rose RD, Roy-Byrne P, Stein MB, Sullivan G, et al. Who gets the most out of cognitive behavioral therapy for anxiety disorders? The role of treatment dose and patient engagement. J Consult Clin Psychol. 2013;81(4):639–649. doi: 10.1037/a0033403.
    1. Cammin-Nowak S, Helbig-Lang S, Lang T, Gloster AT, Fehm L, Gerlach AL, et al. Specificity of homework compliance effects on treatment outcome in CBT: evidence from a controlled trial on panic disorder and agoraphobia. J Clin Psychol. 2013;69(6):616–629. doi: 10.1002/jclp.21975.
    1. Boswell JF, Farchione TJ, Sauer-Zavala S, Murray HW, Fortune MR, Barlow DH. Anxiety sensitivity and interoceptive exposure: a transdiagnostic construct and change strategy. Behav Ther. 2013;44(3):417–431. doi: 10.1016/j.beth.2013.03.006.
    1. McHugh RK, Murray HW, Barlow DH. Balancing fidelity and adaptation in the dissemination of empirically-supported treatments: the promise of transdiagnostic interventions. Behav Res Ther. 2009;47(11):946–953. doi: 10.1016/j.brat.2009.07.005.
    1. Holdsworth E, Bowen E, Brown S, Howat D. Client engagement in psychotherapeutic treatment and associations with client characteristics, therapist characteristics, and treatment factors. Clin Psychol Rev. 2014;34(5):428–450. doi: 10.1016/j.cpr.2014.06.004.
    1. Webb CA, Derubeis RJ, Barber JP. Therapist adherence/competence and treatment outcome: A meta-analytic review. J Consult Clin Psychol. 2010;78(2):200–211. doi: 10.1037/a0018912.
    1. Hogue A, Henderson CE, Dauber S, Barajas PC, Fried A, Liddle HA. Treatment adherence, competence, and outcome in individual and family therapy for adolescent behavior problems. J Consult Clin Psychol. 2008;76(4):544–555. doi: 10.1037/0022-006X.76.4.544.
    1. Devilly GJ, Borkovec TD. Psychometric properties of the credibility/expectancy questionnaire. J Behav Ther Exp Psychiatry. 2000;31(2):73–86. doi: 10.1016/S0005-7916(00)00012-4.
    1. Webb CA, Kertz SJ, Bigda-Peyton JS, Björgvinsson T. The role of pretreatment outcome expectancies and cognitive-behavioral skills in symptom improvement in an acute psychiatric setting. J Affect Disord. 2013;149(1–3):375–382. doi: 10.1016/j.jad.2013.02.016.
    1. Keijsers GP, Schaap CP, Hoogduin CA. The impact of interpersonal patient and therapist behavior on outcome in cognitive-behavior therapy: a review of empirical studies. Behav Modif. 2000;24(2):264–297. doi: 10.1177/0145445500242006.
    1. Flückiger C, Del Re AC, Wampold BE, Symonds D, Horvath AO. How central is the alliance in psychotherapy? A multilevel longitudinal meta-analysis. J Couns Psychol. 2012;59(1):10–17. doi: 10.1037/a0025749.
    1. Horvath AO, Del Re AC, Flückiger C, Symonds D. Alliance in individual psychotherapy. Psychotherapy. 2011;48(1):9–16. doi: 10.1037/a0022186.
    1. Conklin LR, Strunk DR. A session-to-session examination of homework engagement in cognitive therapy for depression: Do patients experience immediate benefits? Behav Res Ther. 2015;72:56–62. doi: 10.1016/j.brat.2015.06.011.
    1. Mausbach BT, Moore R, Roesch S, Cardenas V, Patterson TL. The relationship between homework compliance and therapy outcomes: an updated meta-analysis. Cogn Ther Res. 2010;34(5):429–438. doi: 10.1007/s10608-010-9297-z.
    1. Kazantzis N, Whittington C, Dattilio F. Meta-analysis of homework effects in cognitive and behavioral therapy: a replication and extension. Clin Psychol Sci Pract. 2010;17(2):144–156. doi: 10.1111/j.1468-2850.2010.01204.x.
    1. Hofmann SG, Ellard KK, Siegle GJ. Neurobiological correlates of cognitions in fear and anxiety: a cognitive-neurobiological information-processing model. Cogn Emot. 2012;26(2):282–299. doi: 10.1080/02699931.2011.579414.
    1. Sharp PB, Miller GA, Heller W. Transdiagnostic dimensions of anxiety: neural mechanisms, executive functions, and new directions. Int J Psychophysiol. 2015;98:365–377. doi: 10.1016/j.ijpsycho.2015.07.001.
    1. Fonzo GA, Ramsawh HJ, Flagan TM, Sullivan SG, Simmons AN, Paulus MP, et al. Common and disorder-specific neural responses to emotional faces in generalised anxiety, social anxiety and panic disorders. Br J Psychiatry. 2015;206(3):206–215. doi: 10.1192/bjp.bp.114.149880.
    1. Insel T, Cuthbert B, Garvey M, Heinseen R, Pine DS, Quinn K, et al. Research domain criteria (RDoC): toward a new classification framework for research on mental disorders. Am J Psychiatry. 2010;167(7):748–751. doi: 10.1176/appi.ajp.2010.09091379.
    1. Porto PR, Oliveira L, Mari J, Volchan E, Figueira I, Ventura P. Does cognitive behavioral therapy change the brain? A systematic review of neuroimaging in anxiety disorders. J Neuropsychiatry Clin Neurosci. 2009;21(2):114–125. doi: 10.1176/jnp.2009.21.2.114.
    1. Ball TM, Stein MB, Ramsawh HJ, Campbell-Sills L, Paulus MP. Single-subject anxiety treatment outcome prediction using functional neuroimaging. Neuropsychopharmacology. 2014;39(5):1254–1261. doi: 10.1038/npp.2013.328.
    1. Ito M, Horikoshi M, Kato N, Oe Y, Fujisato H, Nakajima S, et al. Transdiagnostic and transcultural: pilot study of unified protocol for depressive and anxiety disorders in Japan. Behavior Therapy. in press.
    1. Barlow DH, Ellard KK, Fairholme CP, Farchione TJ, Boisseau CL, Allen LB, et al. Unified protocol for transdiagnostic treatment of emotional disorders: client workbook. New York: Oxford University Press; 2011.
    1. Japan Society for Mood Disorders . [Japan Society for Mood Disorders treatment guideline II: Major depressive disorder 2013 ver. 1.1] Tokyo: Japan Society for Mood Disorders; 2013.
    1. Nakagawa A, Williams A, Sado M, Oguchi Y, Mischoulon D, Smith F, et al. Comparison of treatment selections by Japanese and US psychiatrists for major depressive disorder: a case vignette study. Psychiatry Clin Neurosci. 2015;69:553–562.
    1. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23:56–62. doi: 10.1136/jnnp.23.1.56.
    1. Tabuse H, Kalali A, Azuma H, Ozaki N, Iwata N, Naitoh H, et al. The new GRID Hamilton Rating Scale for Depression demonstrates excellent inter-rater reliability for inexperienced and experienced raters before and after training. Psychiatry Res. 2007;153(1):61–67. doi: 10.1016/j.psychres.2006.07.004.
    1. Williams JB, Kobak KA, Bech P, Evans K, Lipsitz J, Olin J, et al. The GRID-HAMD: standardization of the Hamilton Depression Rating Scale. Int Clin Psychopharmacol. 2008;23(3):120–129. doi: 10.1097/YIC.0b013e3282f948f5.
    1. Watanabe N, Furukawa TA, Shimodera S, Morokuma I, Katsuki F, Fujita H, et al. Brief behavioral therapy for refractory insomnia in residual depression: an assessor-blind, randomized controlled trial. J Clin Psychiatry. 2011;72(12):1651–1658. doi: 10.4088/JCP.10m06130gry.
    1. Nakagawa A, Sado M, Mitsuda D, Fujisawa D, Kikuchi T, Abe T, et al. Effectiveness of cognitive behavioural therapy augmentation in major depression treatment (ECAM study): study protocol for a randomised clinical trial. BMJ Open. 2014;4(10):e006359. doi: 10.1136/bmjopen-2014-006359.
    1. Frank E, Prien RF, Jarrett RB, Keller MB, Kupfer DJ, Lavori PW, et al. Conceptualization and rationale for consensus definitions of terms in major depressive disorder: remission, recovery, relapse, and recurrence. Arch Gen Psychiatry. 1991;48(9):851–855. doi: 10.1001/archpsyc.1991.01810330075011.
    1. Shear MK, Vander Bilt J, Rucci P, Endicott J, Lydiard B, Otto MW, et al. Reliability and validity of a structured interview guide for the Hamilton Anxiety Rating Scale (SIGH-A) Depress Anxiety. 2001;13(4):166–178. doi: 10.1002/da.1033.
    1. Inada T, Ozaki N. SIGH-A Japanese Version. Tokyo: The Japanese Society of Psychiatric Rating Scales; 2004.
    1. Guy W. ECDEU assessment manual for psychopharmacology. Rockville: National Institute of Mental Health; 1976.
    1. Busner J, Targum SD. The Clinical Global Impressions Scale: applying a research tool in clinical practice. Psychiatry. 2007;4(7):28–37.
    1. American Psychiatric Association . Diagnostic and statistical manual-IV-text revision (DSM-IV-TR) Washington: American Psychiatric Association; 2000.
    1. First MB, Spitzer RL, Gibbon M, Williams JBW, Benjamin LS. Structured Clinical Interview for DSM-IV® Axis I Disorders (SCID-I), Clinician Version, administration booklet. Arlington: American Psychiatric Publishing; 1997.
    1. Norman SB, Cissell SH, Means-Christensen AJ, Stein MB. Development and validation of an Overall Anxiety Severity and Impairment Scale (OASIS) Depress Anxiety. 2006;23(4):245–249. doi: 10.1002/da.20182.
    1. Ito M, Oe Y, Kato N, Nakajima S, Fujisato H, Miyamae M, et al. Validity and clinical interpretability of Overall Anxiety Severity and Impairment Scale (OASIS) J Affect Disord. 2015;170:217–224. doi: 10.1016/j.jad.2014.08.045.
    1. Bentley KH, Gallagher MW, Carl JR, Barlow DH. Development and validation of the overall depression severity and impairment scale. Psychol Assess. 2014;26:815–830. doi: 10.1037/a0036216.
    1. Ito M, Bentley KH, Oe Y, Nakajima S, Fujisato H, Kato N, et al. Assessing depression related severity and functional impairment: the overall depression severity and impairment scale (ODSIS) PLoS ONE. 2015;10(4):e0122969. doi: 10.1371/journal.pone.0122969.
    1. Beck A, Steer R, Brown G. BDI-II: Beck Depression Inventory, Second Edition, manual. San Antonio: The Psychological Corporation; 1996.
    1. Kojima M, Furukawa TA, Takahashi H, Kawai M, Nagaya T, Tokudome S, et al. Cross-cultural validation of the Beck Depression Inventory-II in Japan. Psychiatry Res. 2002;110(3):291–299. doi: 10.1016/S0165-1781(02)00106-3.
    1. Shear MK, Rucci P, Williams J, Frank E, Grochocinski V, Vander Bilt J, et al. Reliability and validity of the Panic Disorder Severity Scale: replication and extension. J Psychiatr Res. 2001;35(5):293–296. doi: 10.1016/S0022-3956(01)00028-0.
    1. Liebowitz MR. Social phobia. Mod Probl Pharmacopsychiatry. 1987;22:141–173. doi: 10.1159/000414022.
    1. Meyer TJ, Miller ML, Metzger RL, Borkovec TD. Development and validation of the Penn State Worry Questionnaire. Behav Res Ther. 1990;28(6):487–495. doi: 10.1016/0005-7967(90)90135-6.
    1. Goodman WK, Price LH, Rasmussen SA, Mazure C. The Yale–Brown Obsessive-Compulsive Scale. I: Development, use, and reliability. Arch Gen Psychiatry. 1989;46(11):1006–1011. doi: 10.1001/archpsyc.1989.01810110048007.
    1. Weiss DS, Marmar CR. The impact of event scale-revised. Assessing Psychological Trauma and PTSD. 1997;2:168–189.
    1. Asukai N, Kato H, Kawamura N, Kim Y, Yamamoto K, Kishimoto J, et al. Reliabiligy and validity of the Japanese-language version of the Impact of Event Scale-Revised (Ies-RJ): four studies of different traumatic events. J Nerv Ment Dis. 2002;190(3):175–182. doi: 10.1097/00005053-200203000-00006.
    1. Marks IM, Mathews AM. Brief standard self-rating for phobic patients. Behav Res Ther. 1979;17(3):263–267. doi: 10.1016/0005-7967(79)90041-X.
    1. Rabin R, Charro F. EQ-SD: a measure of health status from the EuroQol Group. Ann Med. 2001;33(5):337–343. doi: 10.3109/07853890109002087.
    1. Ikeda S, Shiroiwa T, Igarashi A, Noto S, Fukuda T, Saito S, et al. Developing a Japanese version of the EQ-5D-5 L value set. J Natl Inst Public Health. 2015;64:47–55.
    1. Sheehan DV, Harnett-Sheehan K, Raj BA. The measurement of disability. Int Clin Psychopharmacol. 1996;11(Suppl 3):89–95. doi: 10.1097/00004850-199606003-00015.
    1. Yoshida T, Ohtsubo T, Tsuchida H, Wada Y, Ueshima K, Hukkyo K. Development of Sheehan Disability Scale (SDISS) and its reliability and validity. Jpn JClin Psychopharmacol. 2004;7:1645–1653.
    1. Ito M, Kodama M. Sense of authenticity, self-esteem, and subjective and psychological well-being. Jpn J Educ Psychol. 2005;53(1):74–85. doi: 10.5926/jjep1953.53.1_74.
    1. Kernis MH, Goldman BM. A multicomponent conceptualization of authenticity: theory and research. Adv Exp Soc Psychol. 2006;38:283–357. doi: 10.1016/S0065-2601(06)38006-9.
    1. Joseph S, Wood A. Assessment of positive functioning in clinical psychology: Theoretical and practical issues. Clin Psych Rev. 2010;30(7):830–838. doi: 10.1016/j.cpr.2010.01.002.
    1. Ito M, Horikoshi M, Kodama M. A cross-sectional survey of age and sense of authenticity among Japanese. Psychol Rep. 2009;105(2):575–581. doi: 10.2466/PR0.105.2.575-581.
    1. Eysenck SB, Eysenck HJ, Barrett P. A revised version of the psychoticism scale. Personal Individ Differ. 1985;6(1):21–29. doi: 10.1016/0191-8869(85)90026-1.
    1. Hosokawa T, Ohyama M. Reliability and validity of a Japanese version of the short-form Eysenck Personality Questionnaire-Revised. Psychol Rep. 1993;72(3):823–832. doi: 10.2466/pr0.1993.72.3.823.
    1. Taylor S, Zvolensky MJ, Cox BJ, Deacon B, Heimberg RG, Ledley DR, et al. Robust dimensions of anxiety sensitivity: development and initial validation of the Anxiety Sensitivity Index-3. Psychol Assess. 2007;19(2):176–188. doi: 10.1037/1040-3590.19.2.176.
    1. Berking M, Znoj H. Entwicklung und Validierung eines Fragebogens zur standardisierten Selbsteinschätzung emotionaler Kompetenzen (SEK-27) Z Psychiatr Psychol Psychother. 2008;56(2):141–153.
    1. Duncan BL, Miller S, Sparks JA, Reynolds LR, Brown J, Johnson LD, et al. The Session Rating Scale: preliminary psychometric properties of a “working” alliance measure. J Brief Ther. 2003;3(1):3–12.
    1. Primakoff L, Epstein N, Covi L. Homework compliance: an uncontrolled variable in cognitive therapy outcome research. Behav Ther. 1986;17(4):433–446. doi: 10.1016/S0005-7894(86)80073-9.
    1. US Department of Health and Human Services/National Insititutes of Health/National Cancer Institute . Common Terminology Criteria for Adverse Events (CTCAE) version 4.0. Washington: U.S. Department of Health and Human Services/National Insititutes of Health/National Cancer Institute; 2009.
    1. Roll D, Ray SE, Marcus SM, Passarelli V, Money R, Barlow DH, et al. Independent evaluator knowledge of treatment in a multicenter comparative treatment study of panic disorder. Neuropsychopharmacology. 2004;29(3):612–618. doi: 10.1038/sj.npp.1300373.
    1. Barth J, Munder T, Gerger H, Nüesch E, Trelle S, Znoj H, et al. Comparative efficacy of seven psychotherapeutic interventions for patients with depression: a network meta-analysis. PLoS Med. 2013;10(5):e1001454. doi: 10.1371/journal.pmed.1001454.
    1. Gloaguen V, Cottraux J, Cucherat M, Blackburn IM. A meta-analysis of the effects of cognitive therapy in depressed patients. J Affect Disord. 1998;49(1):59–72. doi: 10.1016/S0165-0327(97)00199-7.
    1. Gould RA, Otto MW, Pollack MH, Yap L. Cognitive behavioral and pharmacological treatment of generalized anxiety disorder: A preliminary meta-analysis. Behav Ther. 1997;28(2):285–305. doi: 10.1016/S0005-7894(97)80048-2.
    1. Gould RA, Ott MW, Pollack MH. A meta-analysis of treatment outcome for panic disorder. Clin Psychol Rev. 1995;15(8):819–844. doi: 10.1016/0272-7358(95)00048-8.
    1. Gould RA, Buckminster S, Pollack MH, Otto MW, Yap L. Cognitive-behavioral and pharmacological treatment for social phobia: A meta-analysis. Clin Psychol Sci Pract. 1997;4(4):291–306. doi: 10.1111/j.1468-2850.1997.tb00123.x.
    1. National Collaborating Center for Mental Health . Post-Traumatic Stress Disorder: the management of PTSD in adults and children in primary and secondary care. Leicester: British Psychological Society/London: Royal College of Psychiatrists; 2005.
    1. Haby MM, Donnelly M, Corry J, Vos T. Cognitive behavioural therapy for depression, panic disorder and generalized anxiety disorder: a meta-regression of factors that may predict outcome. Aust N Z J Psychiatry. 2006;40(1):9–19. doi: 10.1080/j.1440-1614.2006.01736.x.
    1. National Collaborating Centre for Mental Health and Clinical Excellence . Generalised anxiety disorder in adults: Management in Primary, Secondary and Community Care. Leicester: British Psychological Society/London: Royal College of Psychiatrists; 2011.
    1. Singer JD, Willett JB. Applied longitudinal data analysis: modeling change and event occurrence. New York: Oxford University Press; 2003.
    1. Thabane L, Mbuagbaw L, Zhang S, Samaan Z, Marcucci M, Ye C, et al. A tutorial on sensitivity analyses in clinical trials: the what, why, when and how. BMC Med Res Methodol. 2013;13(1):92. doi: 10.1186/1471-2288-13-92.
    1. Cuijpers P, van Straten A, Bohlmeijer E, Hollon SD, Andersson G. The effects of psychotherapy for adult depression are overestimated: a meta-analysis of study quality and effect size. Psychol Med. 2010;40(2):211–223. doi: 10.1017/S0033291709006114.
    1. Carl JR, Soskin DP, Kerns C, Barlow DH. Positive emotion regulation in emotional disorders: a theoretical review. Clin Psychol Rev. 2013;33(3):343–360. doi: 10.1016/j.cpr.2013.01.003.
    1. Ono Y, Furukawa TA, Shimizu E, Okamoto Y, Nakagawa A, Fujisawa D. Current status of research on cognitive therapy/cognitive behavior therapy in Japan. Psychiatry Clin Neurosci. 2011;65(2):121–129. doi: 10.1111/j.1440-1819.2010.02182.x.

Source: PubMed

Sponsorzy i współpracownicy

Warunki medyczne

Interwencje lekowe

3
Subskrybuj